Stated plainly: WXT · cagrilintide.
I have read the primary source rather than the summary, which has left me with more questions.
I understand the headline. I do not understand the footnotes, and the footnotes look important.
What would I need in addition before this supported a decision?
To be exact about it, the certificate is not the answer to your question; it is a data point that you need to combine with other information to build an answer.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
| Test | Answers | Does NOT answer |
|---|---|---|
| RP-HPLC, area % | What fraction of detected material is the target | How much target is present |
| Quantified content | Milligrams of peptide per vial | What the impurities are |
| ESI-MS identity | Whether the molecular weight matches | Purity, or isomeric substitution |
| Peptide mapping | Sequence, localised to a fragment | Quantity |
| Karl Fischer | Water content of the solid | Solvent content |
| LAL endotoxin | Pyrogen load in EU/mg | Sterility |
| Sterility test | Growth in defined media over 14 days | Endotoxin, or bioburden count |
A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.
Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsWorth being precise here: the certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
On the detail: a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
Worth being precise here: the laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
If the certificate does not trace to your vial, it is not evidence about your vial.
Reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
My working rule is that a document without a lot number, a method section and a test date is marketing.
edited 10 Apr 2026 by charge_state_3 — corrected a unit error in the worked example
Most certificates are written to look impressive rather than to be informative, and it is worth being sceptical of that gap.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.